SR-4835

• Description:

  SR-4835 is a highly selective dual inhibitor of CDK12 and CDK13 (CDK12: IC50=99 nM Kd=98 nM; CDK13: Kd=4.9 nM) which disables triple-negative breast cancer (TNBC) cells.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  499.36

• Molecular Formula:

  C21H20Cl2N10O

• Notes:

  Research use only, not for human use.

• Receptor:

  CDK

• CAS Number:

  2387704-62-1